Global DNA Sequencing Market: Key Developments
On January 9, 2023, Illumina Inc., a pharmaceutical company, and Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), announced an agreement with Amgen, a biopharmaceutical company, for whole-genome sequence of DNA samples approximately 35,000 samples. This agreement helped in accelerating therapeutic development through genomics and establish a preeminent clinico-genomic data set.
On December 7, 2022, Element Biosciences, Inc., a developer of the revolutionary DNA sequencing platform, announced the launch of Avidity Cloudbreak Technology. The AVITI technology operates two random access flow cells for independent run starts, with AVITI Operating Software that features tunable read throughput for additional flexibility.
In June 2022, PerkinElmer, Inc., a pharmaceutical company, announced the launch of the BioQule NGS Research System (RUO), an automated benchtop solution for next-generation sequencing (NGS) library preparation. The BioQule NGS System deliver reliability for a wide variety of applications, which researchers require, such as enabling the creation of high-quality NGS libraries that deliver highly reproducible results and genome analysis.
In May 2022, NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced a seamless cloud-based workflow named GeoMx Digital Spatial Profiler. Spatial analysis of the entire transcriptome with proteome analytes can now be simplified using this integrated push-button walk planning tool.
DNA Sequencing Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients